Your browser doesn't support javascript.
loading
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia.
Buske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Veronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V; Tam, Constantine S; Heffner, Leonard T; Varettoni, Marzia; Palomba, M Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israel; Dimopoulos, Meletios A.
Afiliação
  • Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany.
  • Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Trotman J; Concord Hospital, University of Sydney, Sydney, Australia.
  • García-Sanz R; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC & Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.
  • MacDonald D; The Ottawa Hospital, University of Ottawa, Ottawa, Canada.
  • Leblond V; Département d'Hématologie Hôpital Pitié-Salpêtrière AP-HP, Sorbonne Université, Paris, France.
  • Mahe B; Centre Hospitalier Universitaire de Nantes, Hôtel Dieu Hematologie Clinique, Nantes, France.
  • Herbaux C; Centre Hospitalier Régional Universitaire de Lille, Institute of Hematology-Transfusion, Lille, France.
  • Matous JV; Colorado Blood Cancer Institute, Denver, CO, USA.
  • Tam CS; The Alfred Hospital & the University of Melbourne, Melbourne, Australia.
  • Heffner LT; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Varettoni M; Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Palomba ML; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Shustik C; Royal Victoria Hospital at McGill University Health Centre, Montreal, Canada.
  • Kastritis E; National & Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Treon SP; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ping J; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA.
  • Hauns B; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA.
  • Arango-Hisijara I; Janssen Pharmaceuticals, Raritan, NJ, USA.
  • Dimopoulos MA; National & Kapodistrian University of Athens School of Medicine, Athens, Greece.
Future Oncol ; 19(5): 345-353, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36815271
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Idioma: En Ano de publicação: 2023 Tipo de documento: Article